Skip to content
Disclosery

GREYLOCK XII GP LLC

Follow

13F filer, CIK 1413877, Menlo Park, CA

GREYLOCK XII GP LLC reported $49,013,000 across 3 holdings for the quarter ended 2019-06-30, in a 13F-HR filed 2019-08-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-19-007839

Period
2019-06-30
Reported value
$49M
Holdings
3
Top 10 weight
100%
New
1
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
SLACK TECHNOLOGIES INCnew+66,517$2.49M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
KALA BIO INC COMexited-199,613-$1.65M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2019

Share positions as resolved from 13F-HR 0000950123-19-007839, largest first. % of portfolio is the value over $49,012,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
REDFIN CORPREDFIN CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: 8,309,512 shares; 2018Q1: 6,243,262 shares; 2018Q2: 4,177,012 shares; 2018Q3: 4,177,012 shares; 2018Q4: 4,177,012 shares; 2019Q1: 2,087,012 shares; 2019Q2: 2,087,012 shares 2,087,012$37.5M76.56%0
CLOUDERA INCCLOUDERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: 6,744,865 shares; 2018Q1: 6,744,865 shares; 2018Q2: 3,419,865 shares; 2018Q3: 3,419,865 shares; 2018Q4: 1,709,865 shares; 2019Q1: 1,709,865 shares; 2019Q2: 1,709,865 shares 1,709,865$8.99M18.35%0
SLACK TECHNOLOGIES INCSLACK TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: not reported; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: 66,517 shares 66,517$2.49M5.09%new

Sold out in Q2 2019

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
KALA BIO INC COMKALA BIO INC COM199,613$1.65Mshares

How Q2 2019 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-19-007839 base2019-08-14acceptance time not in the bulk data set